Relaxin analogs and derivatives methods and uses thereof

Details Relaxin analogs and derivatives methods and uses thereof Relaxin analogs and derivatives methods and uses thereof

1995-06-07

1998-09-22

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 21, 330399, 330324, A61K 3816, A61K 3817, C07K 710

Patent

active

058113959

ABSTRACT:
The present invention relates to a relaxin analogs and derivatives, and uses thereof. The present invention further relates to compositions comprising a relaxin analogs and derivatives, and relaxin wherein such composition exhibits an additive or synergistic effect.

REFERENCES:
patent: 5023321 (1991-06-01), Hudson et al.
patent: 5166191 (1992-11-01), Cronin et al.
patent: 5179195 (1993-01-01), Hudson et al.
patent: 5451572 (1995-09-01), Cipolla et al.
patent: 5478807 (1995-12-01), Cronin et al.
Bani et al., 1994, "Differentation of breast cancer cells in vitro is promoted by the concurrent influence of myoepithelial cells and relaxin," Bio J. Cancer 70:900-904.
Bryant-Greenwood, 1982, Endocrine Reviews 3:62-90.
Bullesbach and Schwabe, 1991, J. Biol. Chem. 266:10754-10761.
Burkhardt et al., 1994, Genomics 20:13-19.
Osheroff et al., 1990, The Journal of Biological Chemistry 265:9396-9401.
Stemmermann et al., 1994, Journal of Endocrinology 140:321-325.

Affiliated with

Also associated with

Rating

Relaxin analogs and derivatives methods and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Relaxin analogs and derivatives methods and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Relaxin analogs and derivatives methods and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1621808